Business Context and Reporting Period
This Form 8-K is a current report filed by Trovagene, Inc. (not Cardiff Oncology, Inc.) on April 8, 2020. The registrant is a Delaware corporation with its principal executive offices in San Diego, CA, and its common stock trades on the Nasdaq Capital Market under the symbol TROV.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is an "Other Events" filing and does not contain financial statements or performance data.
Material Changes
No material financial changes or operational updates were reported in this filing. The document solely announces a scheduled corporate event.
Guidance, Outlook, and Management Commentary
Upcoming Event: The Company announced it will present at the 19th Annual Needham Healthcare Conference.
- Date: Wednesday, April 15, 2020
- Time: 3:30 p.m. Eastern time
- Format: Virtual conference (held April 14-15, 2020)
No specific financial guidance, risk factors, or contingencies were disclosed in this text.
Investor Verification Checklist
- Verify the correct registrant name is Trovagene, Inc., not Cardiff Oncology, Inc.
- Confirm the virtual presentation details for the Needham Healthcare Conference on April 15, 2020.
- Review the attached press release (Exhibit 99.1) for any additional context not included in the 8-K summary.
- Note that this filing contains no financial data; refer to the most recent 10-Q or 10-K for financial metrics.